Filter news stories by category:
- UCLH news
- Charity news
-
Research news
- Governors news
- Red Cell Network news
- HTD news
- Reset filter
-
Research news
07 April 2021
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
Research news
19 March 2021
University College London Hospitals NHS Foundation Trust (UCLH) and Microsoft have announced a new strategic research and innovation collaboration to develop and apply advances in artificial intelligence (AI) and digital technologies for the future of healthcare delivery in the NHS.
-
Research news
15 February 2021
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
Research news
11 February 2021
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
Research news
04 February 2021
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
Research news
26 January 2021
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
Research news
13 January 2021
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
-
Research news
08 January 2021
UCLH has begun recruiting participants to a trial looking at whether two antiviral drugs given to people who have tested positive for Covid-19 can stop the virus replicating.
-
Research news
30 December 2020
UCLH has welcomed the news that the Oxford-AstraZeneca coronavirus vaccine – which UCLH played a significant role in trialling – has today been approved for use in the UK.
-
Research news
25 December 2020
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.